Literature DB >> 9931308

A transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain.

L P Lam1, R Y Chow, S A Berger.   

Abstract

An activating mutation (DY814) located in the catalytic domain of the c-Kit receptor has been found in mastocytomas from human, mouse and rat. We evaluated the enzymic properties of purified wild-type (WT) and DY814 tyrosine kinase domains expressed in Pichia pastoris. A linker encoding the Flag epitope was fused to c-Kit cDNA species, enabling affinity purification of the proteins with anti-Flag antibodies. Yeast lysates expressing DY814 contained multiple tyrosine-phosphorylated proteins, whereas WT lysates had no detectable tyrosine phosphorylation. Purification of the WT and mutant kinases in the presence of vanadate demonstrated that both enzymes undergo autophosphorylation. Kinetic analyses of WT and DY814 kinases indicated that at 20 nM enzyme concentration the mutation increases the specific activity 10-fold and decreases the apparent Km for ATP 9-fold. WT activity displayed a hyperbolic dependence on enzyme concentration, consistent with a requirement for dimerization or aggregation for activity. This activity was also enhanced by anti-Flag antibodies. In contrast, the dependence of DY814 activity on enzyme concentration was primarily linear and only marginally enhanced by anti-Flag antibodies. Gel-filtration analysis showed that the WT kinase migrated as a monomer, whereas the DY814 mutant migrated as a dimer. These results indicate that this point mutation promotes dimerization of the c-Kit kinase, potentially contributing to its transforming potential in mast cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931308      PMCID: PMC1220034     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity.

Authors:  A Yoshimura; G Longmore; H F Lodish
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

3.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation.

Authors:  C H Heldin; A Ernlund; C Rorsman; L Rönnstrand
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

4.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor.

Authors:  M F White; S E Shoelson; H Keutmann; C R Kahn
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

5.  The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.

Authors:  J C Tan; K Nocka; P Ray; P Traktman; P Besmer
Journal:  Science       Date:  1990-01-12       Impact factor: 47.728

6.  Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.

Authors:  K M Zsebo; D A Williams; E N Geissler; V C Broudy; F H Martin; H L Atkins; R Y Hsu; N C Birkett; K H Okino; D C Murdock
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Activation of the EGF receptor tyrosine kinase by divalent metal ions: comparison of holoreceptor and isolated kinase domain properties.

Authors:  J G Koland; R A Cerione
Journal:  Biochim Biophys Acta       Date:  1990-05-22

8.  Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor.

Authors:  P B Wedegaertner; G N Gill
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

9.  Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.

Authors:  L Hubler; P S Leventhal; P J Bertics
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

10.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

View more
  5 in total

Review 1.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

Review 2.  More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.

Authors:  Devan Diwanji; Tarjani Thaker; Natalia Jura
Journal:  IUBMB Life       Date:  2019-05-02       Impact factor: 3.885

Review 3.  Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

Authors:  Glenn Cruse; Dean D Metcalfe; Ana Olivera
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-12       Impact factor: 3.479

Review 4.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

Review 5.  Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Authors:  Maryam Abbaspour Babaei; Behnam Kamalidehghan; Mohammad Saleem; Hasniza Zaman Huri; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2016-08-01       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.